Doctor profile · Federal record
Dr. Carlos Medina Mendez, M.D.
Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Ophthalmology Physician · Sacramento, CA
- NPI 1811218316
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 18 yrs in practice
- Licensed in 4 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3939 J St, Suite 106
Sacramento, CA 958193636
(916) 454-4861
Credentials & registration
- NPI registered
- June 2010 — 16 yrs on file
- Profile last updated
- April 3, 2017
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State licenses (4)
- California #138518 · Pennsylvania #MT194706 · New Mexico #RS2013-0129 · Florida #ME118992
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811218316. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
55,009
Distinct HCPCS
10
Medicare allowed
$7,678,443
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 33,060 | 117 | $36 | |
J0178 |
Injection, aflibercept, 1 mg | 4,710 | 489 | $864 | |
92134 |
Imaging of retina | 4,532 | 1,697 | $43 | |
67028 |
Injection of drug into eye | 3,353 | 871 | $135 | |
Q5124 |
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 3,105 | 124 | $213 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 1,242 | 101 | $231 | |
92012 |
Established patient problem focused exam of visual system | 1,189 | 594 | $96 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 951 | 776 | $95 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 577 | 63 | $271 | |
92235 |
Exam of retinal blood vessels using a special camera after injection of a dye | 536 | 498 | $149 |
In context: peer comparison
Among 10 peers in Sacramento Retina Specialist (Ophthalmology) Physician, average services per provider: 1,157. This provider delivers 48× the peer median.Open Payments
Industry payments received
All-time total
$164,617
Transactions
178
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US INC | 73 | $59,079.14 | |
| Genentech USA, INC. | 47 | $42,250.66 | |
| Apellis Pharmaceuticals, INC. | 21 | $35,526.51 | |
| Regeneron Healthcare Solutions, INC. | 17 | $19,986.85 | |
| Regeneron Pharmaceuticals, INC. | 4 | $5,683.01 | |
| EyePoint Pharmaceuticals US, INC. | 7 | $1,625.63 | |
| Alimera Sciences, INC. | 3 | $223.79 | |
| Biogen, INC. | 3 | $133.19 | |
| Alcon Vision LLC | 1 | $58.08 | |
| Genentech, INC. | 1 | $26.30 | |
| Amgen INC. | 1 | $24.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
482
Patients
282
Total drug cost
$16,571
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 149 | 108 | $8,224 |
| Ketorolac Tromethamine | Generic | 119 | 48 | $4,651 |
| Ofloxacin | Generic | 84 | 73 | $1,316 |
| Brimonidine Tartrate | Generic | 40 | 22 | $705 |
| Timolol Maleate | Generic | 32 | 17 | $329 |
| Dorzolamide Hcl | Generic | 28 | 14 | $604 |
| Latanoprost | Generic | 19 | 0 | $340 |
| Atropine Sulfate | Generic | 11 | 0 | $401 |
Frequently asked questions
What is Dr. Carlos Medina Mendez's medical specialty?
Dr. Carlos Medina Mendez practices Retina Specialist (Ophthalmology) Physician in Sacramento, CA.
Where does Dr. Carlos Medina Mendez practice?
Dr. Carlos Medina Mendez practices at 3939 J St, Sacramento, CA 958193636. Office phone: 9164544861.
What is Dr. Carlos Medina Mendez's NPI?
Dr. Carlos Medina Mendez's National Provider Identifier (NPI) is 1811218316, issued by NPPES.
Does Dr. Carlos Medina Mendez accept Medicare assignment?
Yes. Dr. Carlos Medina Mendez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Carlos Medina Mendez commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, aflibercept, 1 mg (HCPCS J0178); Imaging of retina (HCPCS 92134). Source: CMS Medicare Physician & Other Practitioners file.